Waltz Health and Fresenius Kabi will offer three biosimilars through a direct-to-payer model that bypasses traditional wholesaler and PBM rebate channels.
News|Articles|October 1, 2026
Doceree CEO: AI Should Extend the Field Force, Not Replace It
Author(s)Harshit Jain, Stephen Appezzato
In this Q&A, Doceree CEO Harshit Jain, MD, explains why AI should inform prescribing decisions, not drive them, and how sales reps own relationships while AI extends reach.
Advertisement
Advertisement
AI has moved from pilot projects into pharma's commercial operations, and sales and marketing is one of the areas where manufacturers say it is already paying off. In a survey of 115 U.S.-based technology executives at multinational pharma and biotech companies, 47% said they are consistently demonstrating measurable value from AI and digital investments in commercial sales and marketing, including healthcare professional (HCP) engagement and personalization. Those same executives remain cautious about how far AI should go with customers. In customer- and patient-facing functions, most favored smaller-scale use cases built on human-in-the-loop task automation or assistants and copilots.¹
Related to this article
The EU's pharma reform makes market protection more conditional. Here is how US drugmakers, especially startups, can adapt and use IP to complement it.
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.
Authenticx CEO Amy Brown on why patient support AI needs continuous oversight, not just adoption.
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
Mike Hennessy Jr. on the commercial assumptions being rewritten across pricing, patient engagement and supply chain in PC's October 2026 print issue.
Patient support data that is trusted, connected and delivered into field workflows can move access teams from reporting to faster patient intervention.
In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.
Advertisement
Advertisement